Clinical Trials Browser

Phase 3 × Multiple Myeloma × Fibroblast Growth Factor 7 × Clear all

NCT00434161 2015-03-30

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

Phase 3 Completed

281 enrolled 27 charts

Cataract, Multiple Myeloma, Neoplasms, Stomatitis